Drug Utilisation Sub-Committee utilisation analysis public release documents

10 July 2020 - The utilisation analysis public release documents from the February 2020 Drug Utilisation Sub-Committee meeting are now available. ...

Read more →

Public Summary Documents - March 2020 PBAC meeting

3 July 2020 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2020 PBAC ...

Read more →

Final report for the post-market review of pulmonary arterial hypertension medicines

25 May 2020 - The final report and outcomes of the post-market review of pulmonary arterial hypertension medicines are now publicly ...

Read more →

Half yearly performance snapshot: July to December 2019

6 May 2020 - The TGA prepares an annual TGA Business Plan, which identifies the priority activities being undertaken over the ...

Read more →

EMA publishes minutes of joint meeting with EUnetHTA - November 2019

5 May 2020 - This was the 18th meeting between the EMA and representatives from the EUnetHTA and attended by the ...

Read more →

Procedure Guidance for standardised redactions to PBAC Public Summary Documents

30 April 2020 - The PBAC has indicated its preference for greater transparency to be introduced in PSDs through a ...

Read more →

Public Summary Documents - December 2019 PBAC meeting

9 April 2020 - The Public Summary Documents relating to the December 2019 PBAC meeting are now available. ...

Read more →

Public Summary Documents - November 2019 PBAC meeting (supplement)

26 March 2020 - Additional insights from the second round of public summary documents (first time rejections and deferrals). ...

Read more →

Public Summary Documents - November 2019 PBAC meeting

25 March 2020 - Insights from the second round of public summary documents (first time rejections and deferrals). ...

Read more →

PBAC Public Summary Documents - November 2019 meeting (first time rejections and deferrals)

20 March 2020 - The public summary documents (first rejections and deferrals) from the November 2019 PBAC meeting are now available. ...

Read more →

ICER releases draft evidence report on obeticholic acid for non-alcoholic steatohepatitis

19 March 2020 - Public comment period on preliminary draft now open until 24 June 2020; requests to make oral comment ...

Read more →

Drug Utilisation Sub-Committee outcome statement

18 March 2020 - The outcome statement from the February 2020 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

ICER releases evidence report on treatments for sickle cell disease

12 March 2020 - Three new treatments use different mechanisms to improve patient outcomes, offering important options for patients. ...

Read more →

Standardised redactions to Public Summary Documents – nominations open for participation in the final trial, and implementation from July 2020

5 March 2020 - The Department is now seeking nominations from sponsors with submissions due to be considered at the ...

Read more →

ICER issues final report and policy recommendations on acute treatments for migraine

25 February 2020 - Evidence on new agents lasmiditan, ubrogepant, and rimegepant judged inadequate to demonstrate superiority over more affordable triptans. ...

Read more →